...
首页> 外文期刊>Catheterization and cardiovascular interventions: Official journal of the Society for Cardiac Angiography & Interventions >Elective coronary stent implantation in cardiogenic shock complicating acute myocardial infarction: in-hospital and six-month clinical and angiographic results.
【24h】

Elective coronary stent implantation in cardiogenic shock complicating acute myocardial infarction: in-hospital and six-month clinical and angiographic results.

机译:心源性休克并发急性心肌梗死的选择性冠状动脉支架植入术:住院及六个月临床和血管造影结果。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Effective treatment of patients with acute myocardial infarction and cardiogenic shock depends on restoring persistent patency of the infarct-related artery. Coronary stenting, reducing abrupt or delayed closure related to dissection and suboptimal result, may improve PTCA results in cardiogenic shock. Eighteen patients (14 males and 4 females, mean age 59 +/- 7 years), referred to catheterization laboratory for acute myocardial infarction and shock, had elective stent implantation during 14 primary and 4 rescue PTCA. Time delay between shock onset and PTCA was 4.1 +/- 3 hr (range, 30 min to 12 hr). The IRA was LAD in seven patients (38%), LCx in two (11%), and RCA in eight (45%). One patient (5.%) had distal LMCA occlusion. Stent deployment was successful in 100% of patients and resulted in TIMI 3 flow in 13 (72%) patients. In 13 (72%) cases, cardiogenic shock gradually resolved and the patients were discharged alive. Five patients (28%) died because of irreversible hemodynamic deterioration without evidence of reinfarction. At 6-month follow-up, all the discharged patients were alive and no patient had reinfarction or recurrent angina. Heart transplant was required in one patient 5 months after stenting because of refractory congestive heart failure. Angiography demonstrated patency of all the coronary arteries treated, with TIMI 3 flow in all patients. Stent restenosis rate was 30%, and target lesion revascularization with CABG or re-PTCA was not required in any case. LV function improved from 39% +/- 15% to 51% +/- 15% (P < 0.01). Elective coronary stenting is an effective treatment for acute myocardial infarction complicated by cardiogenic shock and may improve acute and long-term survival.
机译:对急性心肌梗塞和心源性休克患者的有效治疗取决于恢复梗塞相关动脉的持续通畅。冠状动脉支架置入术可减少与解剖和次优结果相关的突然或延迟闭合,可改善PTCA导致心源性休克的结果。 18例患者(男14例,女4例,平均年龄59 +/- 7岁)因急性心肌梗塞和休克转入导管实验室,在14例初次PTCA和4例PTCA抢救期间进行了选择性支架植入。休克发作与PTCA之间的时间延迟为4.1 +/- 3小时(范围为30分钟至12小时)。 IRA为7例(38%)为LAD,2例(11%)为LCx,8例(45%)为RCA。 1名患者(5.%)患有远端LMCA闭塞。支架部署在100%的患者中成功完成,并导致13(72%)名患者的TIMI 3流量。在13例(72%)的病例中,心源性休克逐渐消退,患者康复。五例患者(28%)由于不可逆的血液动力学恶化而死亡,而没有再梗塞的迹象。在6个月的随访中,所有出院的患者都还活着,没有患者再梗塞或复发性心绞痛。由于难治性充血性心力衰竭,置入支架后5个月的一名患者需要进行心脏移植。血管造影显示所有治疗的冠状动脉通畅,所有患者均接受TIMI 3血流。支架再狭窄率为30%,在任何情况下均不需要使用CABG或re-PTCA进行靶病变血运重建。左室功能从39%+/- 15%提高到51%+/- 15%(P <0.01)。选择性冠状动脉支架置入术是治疗急性心肌梗死并发心源性休克的有效方法,可以提高急性和长期生存率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号